INDSWFTLAB

Ind-Swift Laboratories Share Price

 

 

Start SIP in INDSWFTLAB

Start SIP

Performance

  • Low
  • ₹132
  • High
  • ₹140
  • 52 Week Low
  • ₹69
  • 52 Week High
  • ₹140
  • Open Price₹132
  • Previous Close₹132
  • Volume1,575,312
  • 50 DMA₹105.21
  • 100 DMA₹102.26
  • 200 DMA₹101.46

Investment Returns

  • Over 1 Month + 52.1%
  • Over 3 Month + 37.96%
  • Over 6 Month + 39.98%
  • Over 1 Year + 34.62%

Smart Investing Starts Here Start SIP with Ind-Swift Laboratories for Steady Growth!

Invest Now

Ind-Swift Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 4.6
  • PEG Ratio
  • 1.3
  • Market Cap Cr
  • 1,133
  • P/B Ratio
  • 0.9
  • Average True Range
  • 7.32
  • EPS
  • 5.8
  • Dividend Yield
  • 0
  • MACD Signal
  • 5.56
  • RSI
  • 80.06
  • MFI
  • 96.01

Ind-Swift Laboratories Financials

Ind-Swift Laboratories Technicals

EMA & SMA

Current Price
₹138.79
+ 6.59 (4.98%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹113.32
  • 50 Day
  • ₹105.21
  • 100 Day
  • ₹102.26
  • 200 Day
  • ₹101.46

Resistance and Support

137.06 Pivot Speed
  • R3 149.04
  • R2 144.47
  • R1 141.63
  • S1 134.22
  • S2 129.65
  • S3 126.81

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Ind-Swift Labs. (Nse) has an operating revenue of Rs. 594.47 Cr. on a trailing 12-month basis. An annual revenue de-growth of -52% needs improvement, Pre-tax margin of 46% is great, ROE of 21% is exceptional. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 32% and 34% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 17% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 98 which is a GREAT score indicating consistency in earnings, a RS Rating of 92 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 59 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Overall, the stock has great fundamentals and technical strength to stay in momentum.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Ind-Swift Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-01-31 Quarterly Results
2025-11-14 Quarterly Results
2025-08-13 Quarterly Results
2025-08-11 Audited Results
2025-05-30 Audited Results

Ind-Swift Laboratories F&O

Ind-Swift Laboratories Shareholding Pattern

39.5%
0%
14.33%
0%
35.07%
11.1%

About Ind-Swift Laboratories

  • NSE Symbol
  • INDSWFTLAB
  • BSE Symbol
  • 532305
  • Chairman & Managing Director
  • Mr. Navrattan Munjal
  • ISIN
  • INE915B01019

Similar Stocks to Ind-Swift Laboratories

Ind-Swift Laboratories FAQs

Ind-Swift Laboratories share price is ₹138 As on 10 February, 2026 | 01:40

The Market Cap of Ind-Swift Laboratories is ₹1132.7 Cr As on 10 February, 2026 | 01:40

The P/E ratio of Ind-Swift Laboratories is 4.6 As on 10 February, 2026 | 01:40

The PB ratio of Ind-Swift Laboratories is 0.9 As on 10 February, 2026 | 01:40

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23